InvestmentsTop Global NewsMarketsReal Estate Amgen 2020 outlook falls short of Street estimates, shares down 3per cent By financialnews_rlv83x - January 30, 2020 0 110 Amgen Inc on Thursday forecast 2020 earnings well short of current Wall Street estimates, sending shares of the largest U.S. biotechnology company down 3per cent.